Michael Grobstein - Net Worth and Insider Trading
Michael Grobstein Net Worth
The estimated net worth of Michael Grobstein is at least $373,057 dollars as of 2024-04-23. Michael Grobstein is the Director of Mead Johnson Nutrition Co and owns about 4,146 shares of Mead Johnson Nutrition Co (MJN) stock worth over $373,057. Details can be seen in Michael Grobstein's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael Grobstein has not made any transactions after 2015-07-28 and currently still holds the listed stock(s).
Transaction Summary of Michael Grobstein
Michael Grobstein Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Grobstein owns 2 companies in total, including Bristol-Myers Squibb Co (BMY) , and Mead Johnson Nutrition Co (MJN) .
Click here to see the complete history of Michael Grobstein’s form 4 insider trades.
Insider Ownership Summary of Michael Grobstein
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BMY | Bristol-Myers Squibb Co | 2007-03-06 | director |
| MJN | Mead Johnson Nutrition Co | 2017-06-15 | director |
Michael Grobstein Latest Holdings Summary
Michael Grobstein currently owns a total of 1 stock. Michael Grobstein owns 4,146 shares of Mead Johnson Nutrition Co (MJN) as of July 28, 2015, with a value of $373,057.
Latest Holdings of Michael Grobstein
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MJN | Mead Johnson Nutrition Co | 2015-07-28 | 4,146 | 89.98 | 373,057 |
Holding Weightings of Michael Grobstein
Michael Grobstein Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Grobstein has made a total of 0 transactions in Mead Johnson Nutrition Co (MJN) over the past 5 years. The most-recent trade in Mead Johnson Nutrition Co is the acquisition of 2,000 shares on July 28, 2015, which cost Michael Grobstein around $179,660.
Insider Trading History of Michael Grobstein
- 1
Michael Grobstein Trading Performance
GuruFocus tracks the stock performance after each of Michael Grobstein's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Grobstein is -11.46%. GuruFocus also compares Michael Grobstein's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Grobstein within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Grobstein's insider trading performs compared to the benchmark.
Performance of Michael Grobstein
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -12.79 | -11.46 | -22.08 | -0.22 | ||
| Relative Return to S&P 500(%) | -7.8 | -11.32 | -12.53 | -3.88 |
Michael Grobstein Ownership Network
Ownership Network List of Michael Grobstein
Ownership Network Relation of Michael Grobstein
Michael Grobstein Owned Company Details
What does Bristol-Myers Squibb Co do?
Who are the key executives at Bristol-Myers Squibb Co?
Michael Grobstein is the director of Bristol-Myers Squibb Co. Other key executives at Bristol-Myers Squibb Co include EVP & Chief Commercial Officer Christopher S. Boerner , EVP & Corporate Affairs Cari Gallman , and SVP & Human Resources Ann Powell Judge .
Bristol-Myers Squibb Co (BMY) Insider Trades Summary
Over the past 18 months, Michael Grobstein made no insider transaction in Bristol-Myers Squibb Co (BMY). Other recent insider transactions involving Bristol-Myers Squibb Co (BMY) include a net sale of 45,419 shares made by Ann Powell Judge , a net sale of 96,295 shares made by Rupert Vessey , and a net purchase of 5,071 shares made by Christopher S. Boerner .
In summary, during the past 3 months, insiders sold 0 shares of Bristol-Myers Squibb Co (BMY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 382,446 shares of Bristol-Myers Squibb Co (BMY) were sold and 13,571 shares were bought by its insiders, resulting in a net sale of 368,875 shares.
Bristol-Myers Squibb Co (BMY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bristol-Myers Squibb Co Insider Transactions
Michael Grobstein Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Grobstein. You might contact Michael Grobstein via mailing address: C/o Guidant Corp, 111 Monument Circle #2900, Indianapolis In 46204-5129.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
